Prevention

Obesity Phenotypes: Personalizing Treatment Beyond BMI

Contraception Decision-making for Pre-menopausal Women with Cardiovascular Disease

Menopause Management In Women with Cardiovascular Disease

Cardiovascular Care of the Master’s Athlete

Pregnancy, Labor and Delivery, and Postpartum Care in Women with Cardiovascular Disease

Does Lifestyle Affect Pregnancy and Congenital Birth Defects?

Length: 00:21:27

Translating the DGA Into Real-World Cardiometabolic Care

Length: 00:31:01

Applications of the New DGA

Length: 00:32:01

Dietary Guidelines of America: What Changed, What Didn’t, and Why it Matters

Length: 00:31:11

Obesity, Hypertension, and Risk Factors in Terms of Prevention and Decreasing the Risk of HfpEF

Cardiovascular Diet Myths

Heart Healthy Diet: How to Evaluate Your Patients

Effects of Social Isolation and Loneliness on the Heart

Ischemia with No Obstructive Arteries (INOCA) in 2024

Statin Myopathy

What is ECG Age vs Chronologic Age and How to Use it in Your CV Prevention Practice

Ceramide Risk Score: How Does it Differ From Hs CRP and How to Incorporate it Into Your CV Prevention Practice

Ceramide Risk Score: How Does it Differ From Hs CRP and How to Incorporate it Into Your CV Prevention Practice

Ceramide Risk Score: How Does it Differ From Hs CRP and How to Incorporate it Into Your CV Prevention Practice

Management of Postoperative Pericarditis

CT Scan for Coronary Artery Calcification Window

How a Years Worth of Experience of PFA for AF has Revolutionized My Practice

Lipoprotein (a) Elevation: What Does it do to Increase CV Risk and What do you Need to Know About Treatment

How to Tell Patients about Adding in Intervals to Their Physical Activity Program

Interval Training-What Does the Science Tell Us About the Benefits Versus Continuous Activity

Interview with the Experts: Secrets to Achieving CAD Regression

Lifestyle Modifications in the Setting of New Prevention Therapies

Lifestyle Modifications in the Setting of New Prevention Therapies

New RNA therapies for treatment of ASCVD, Prevention and Dyslipidemia

Lipid Drugs Part II

Lipid Drugs Part I

Antiplatelets after Stenting

Length: 00:19:02

Current Nutritional Controversies

Length: 00:37:03

Can CT Angiography Be Used To Track CAD Regression?

Length: 00:09:07

Myth-Busting: Common Misconceptions About Dairy and Heart Health, Personalized Nutrition and Dairy, & Practical Tips for Heart-Healthy Dairy Consumption

The Role of Saturated Fats in Dairy & Dairy Alternatives and Their Impact

Introduction to Dairy and Cardiovascular Health and the Science Behind Dairy and Heart Health

Left Atrial Appendage Occlusion or Anticoagulation for Stroke Prevention in A Fib

Length: 00:14:37

Clinical Utility of Coronary Calcium Score. A Guide for Practitioners

Length: 00:19:34

Mediterranean Diet

Length: 00:14:25

Does Sleep Loss Affect Your Heart?

Length: 00:19:10

Pharmacologic Therapies for Obesity: The Future is Here

Length: 00:18:23

Lipid Management Post ACS or Revascularization – What Therapies Should be Combined?

Length: 00:16:13

What is a Cardio-Protective Diet?

Length: 00:19:10

Delivery of ASCVD Secondary Prevention Strategies for Rural Communities

Length: 00:18:01

Peripheral Artery Disease (PAD) Treatment

Length: 00:23:22

Inflammation and Heart Disease (CRP, ESR)

Length: 00:19:43

FH: What it is, Increased Cardiovascular Risk, Ruling Out Secondary Causes, and When to Refer

Length: 00:12:43

Frailty and Cardiovascular Diseases

Length: 00:20:29

Effects of a Low-Carbohydrate Diet on Insulin-Resistant Dyslipoproteinemia-a Randomized Controlled Feeding Trial

Length: 00:10:51

Inclisiran – How does it really work?

Length: 00:19:31